Die folgenden Begriffe wurden einbezogen:
Parkinson-Krankheit, "Parkinson's disease", パーキンソン病
-
2005,
Park RM, Schulte PA, Bowman JD, Walker JT, Bondy SC, Yost MG, Touchstone JA, Dosemeci M
Am J Ind Med 48 (1): 63-77
-
2005,
Feychting M, Ahlbom A, Kheifets L
[Details]
EMF and health
[Review]
Annu Rev Public Health 26: 165-189
-
2005,
Benabid AL, Wallace B, Mitrofanis J, Xia C, Piallat B, Fraix V, Batir A, Krack P, Pollak P, Berger F
C R Biol 328 (2): 177-186
-
Arch Neurol 61 (6): 977
-
2004,
Martinelli PT, Schulze KE, Nelson BR
Dermatol Surg 30 (7): 1021-1030
-
2003,
Hakansson N, Gustavsson P, Johansen C, Floderus B
Epidemiology 14 (4): 420-426
-
2002,
Noonan CW, Reif JS, Yost M, Touchstone J
Scand J Work Environ Health 28 (1): 42-48
-
Ugeskr Laeger 164 (1): 50-54
-
2001,
Sieron A, Brus R, Szkilnik R, Plech A, Kubanski N, Cieslar G
Bioelectromagnetics 22 (7): 479-486
-
2001,
Schüz J, Michaelis J
Umweltmed Forsch Prax 6 (2): 67-76
-
Bioelectromagnetics: S132-S143
-
2000,
Quinn N, Maraganore D
Mov Disord 15 (3): 587-588
-
Neurosci Behav Physiol 30 (2): 187-194
-
Epidemiology 11 (5): 539-543
-
Radiats Biol Radioecol 40 (2): 217-225
-
2000,
Schuurman PR, Bosch DA, Bossuyt PM, Bonsel GJ, van Someren EJ, de Bie RM, Merkus MP, Speelman JD
N Engl J Med 342 (7): 461-468
-
1999,
Cruz DC, Nelson LM, McGuire V, Longstreth Jr WT
Neuroepidemiology 18 (2): 101-110
-
1999,
Merello M, Nouzeilles MI, Kuzis G, Cammarota A, Sabe L, Betti O, Starkstein S, Leiguarda R
Mov Disord 14 (1): 50-56
-
1999,
Barcia-Salorio JL, Roldan P, Talamantes F, Pascual-Leone A
Stereotact Funct Neurosurg 72 (2-4): 202-207
-
Int J Neurosci 97 (1-2): 139-145
-
Int J Neurosci 97 (3-4): 225-233
-
J Neurosci Res 57 (6): 935-940
-
N Engl J Med 340 (19): 1500-1502
-
1999,
Bejjani BP, Damier P, Arnulf I, Thivard L, Bonnet AM, Dormont D, Cornu P, Pidoux B, Samson Y, Agid Y
N Engl J Med 340 (19): 1476-1480
-
Int J Neurosci 99 (1-4): 139-149